OQS
VIRX

Occudo Quantitative Strategies’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,874
Closed -$18.8K – 1260
2022
Q4 		$18.8K Sell
12,874
-10
-0.1% -$29 ﹤0.01% 913
2022
Q3 		$55K Sell
12,884
-1,566
-11% -$6.63K ﹤0.01% 1083
2022
Q2 		$56K Sell
14,450
-5,155
-26% -$14.7K ﹤0.01% 1062
2022
Q1 		$93K Sell
19,605
-13,046
-40% -$39.3K 0.01% 1022
2021
Q4 		$119K Buy
+32,651
New +$174K 0.01% 940

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Occudo Quantitative Strategies's VIRX Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2023, closing a stake of 12,874 shares — an estimated $18.8K sold.

Occudo Quantitative Strategies first reported a position in VIRX in Q4 2021 and held it in 5 quarters. The position peaked at $119K in Q4 2021. 48 funds tracked by Wall St. Rank hold VIRX as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,874 Viracta Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $18.8K.
  • Occudo Quantitative Strategies first reported a position in Viracta Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Viracta Therapeutics, Inc. Common Stock position peaked at $119K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.